PC rescue of mutant NK3Rs, therefore, may represent a valid therapeutic option in the treatment of hypogonadism resulting from NK3R-inactivating point mutations which cause intracellular retention and poor cell surface expression. This evidence concerns the gene TACR3 and hypogonadism.